MAYO CLINIC HEALTH SYS - NEW PRAGUE — History
CCN 241361 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$71M
Latest Revenue (FY2022)
+12.4%
Revenue CAGR (3yr)
8.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $56M | $66M | $71M | +7.0% | +12.4% |
| Operating Expenses | $61M | $70M | $65M | -6.8% | +2.9% |
| Operating Margin | -9.0% | -4.8% | 8.7% | +281.3% | +0.0% |
| Net Income | $-5M | $-3M | $6M | +294.0% | +0.0% |
| Licensed Beds | 20 | 20 | 20 | +0.0% | +0.0% |
| Total Patient Days | 3,707 | 4,134 | 5,125 | +24.0% | +17.6% |
| Medicare Day % | 44% | 47% | 48% | +2.1% | +3.5% |
| Medicaid Day % | 11% | 8% | 12% | +44.1% | +3.3% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +26.4% ($56M → $71M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+12.4%
This Hospital
+7.6%
State Avg
Latest Margin
8.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $79M | 17.6% |
| FY2024 (proj) | $86M | 26.4% |
| FY2025 (proj) | $93M | 35.2% |